Navigation Links
Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
Date:11/13/2009

valents and restricted cash totaled $14.4 million on September 30, 2009 compared to $12.4 million on June 30, 2009. The Company had a current ratio of 5.8 to 1 and total stockholders' equity of 46.2 million, which includes noncontrolling interest of $0.4 million, with total assets of $50.8 million versus total liabilities of $4.6 million on September 30, 2009. For the first three months of fiscal 2010, the Company generated $2.2 million in cash from operations versus $0.5 million for the same period in fiscal 2009.

Business Development & Outlook

On September 28, 2009, Tianyin appointed Mr. Tao Yang to the position of Chief Operating Officer. Mr. Yang has more than 18 years experience in the sales and marketing industry. He was appointed in November 2008 as Chief Advisor for Sales and Marketing and Special Advisor to Dr. Jiang, the CEO of the Company. Since then, Mr. Yang has helped implement a strategy to boost sales of leading products and further improve the efficiency of Tianyin's sales and marketing team.

On October 29, 2009, Tianyin announced it has formed a joint venture with Sichuan Mingxin Pharmaceutical Co., Ltd ("Mingxin") named Sichuan Jiangchuan Pharmaceutical Co., Ltd. ("Jiangchuan"). Tianyin owns 77% of Jiangchuan and will utilize this as the foundation for a broader, longer-term strategy to build a significant presence in the rapidly growing Chinese macrolide antibiotics market, while diversifying its revenue base of western pharmaceuticals.

On October 29, 2009 management increased fiscal 2010 guidance for the year which ends June 30, 2010 and expects to report revenues of more than $63.6 million and net income of at least $11.3 million, representing 48.3% and 43.0% year-over-year growth respectively.

"The Chinese stimulus plan and favorable policies for the health care industry are now starting to manifest themselves throughout the pharmaceutical industry by driving
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Tianyin Pharmaceutical, Co. Announces Cash Dividend to Common Shareholders - Record Date October 30, 2009
2. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
3. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
4. Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media
5. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
6. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
7. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
8. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
9. Endo Pharmaceuticals and LecTec Settle Patent Dispute
10. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
11. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... TITUSVILLE, N.J. , March 29, 2015 /PRNewswire/ ... delayed time to relapse compared to placebo in ... 3 clinical study published this week in the ... (JAMA) Psychiatry . Results of ... recent New Drug Application (NDA) filing for three-month ...
(Date:3/27/2015)... March 27, 2015 Across the global healthcare ... challenges in clinical development, market education, and regulatory compliance. ... Medical Affairs function is expected to increase in prominence ... According to research by benchmarking firm, Best ... group dedicated to Medical Affairs. Among companies in ...
(Date:3/27/2015)... , March 27, 2015 /CNW/ - Covalon Technologies Ltd. ... technologies company, today announced the issuance of an aggregate ... the Company and an aggregate of 120,500 stock options ... options will vest over three years and will be ... exercise price of $1.40 per stock option. ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Covalon Announces Issuance of Stock Options 2
... LAIYANG, China , June 4 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, ... its principal operations in China , today,announced that the Company has ... , , ... anticipates that its common stock will begin trading on the NASDAQ,Global Market ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ), a specialty ... Chief Executive Officer A.J. Kazimi will present a corporate overview at ... Eastern Time on Wednesday, June 23, 2010 . , ... The presentation will be simultaneously webcast and can ...
Cached Medicine Technology:Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 2Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 3Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010 2
(Date:3/30/2015)... March 30, 2015 Tel-Aviv – March ... prescription eyewear, announced the closing of $12.5 million in ... of the Viola Group. The funding will further GlassesUSA's ... leading player in the growing global market of online ... in 2009 by CEO Daniel Rothman, COO Eldad Rothman, ...
(Date:3/30/2015)... Dr. Shahdad Arami is now offering ... $200 off their Invisalign treatment. Many people crave straighter ... mouthful of metal. Invisalign offers an alternative. According to ... effective for straightening teeth but has no aesthetic value ... appearance. The Invisalign system allows both teenagers and adults ...
(Date:3/30/2015)... Valerie Harper, the actress best known as ... Mary Tyler Moore Show,” will be the keynote speaker ... magazine announced today. Harper, who is living with terminal ... 40th Annual Congress on April 23 in Orlando, Fla. ... play in the lives of people with cancer. Nominated ...
(Date:3/30/2015)... GenSight ®, provider of an ... leader in The Forrester Wave™: Strategic Planning For The ... independent report positions GenSight as a leader and gave ... 5) for the analytics, corporate strategy, assessment, direction and ... position in the Leaders category. , According to the ...
(Date:3/30/2015)... In an email sent to ECOBOND® LBP, ... TN Community Development Department, announced: “I specifically named Ecobond ... work”. , ECOBOND® LBP, patented lead ... and surpasses other lead paint products because it is ... treats lead dust and lead in paint. While lead ...
Breaking Medicine News(10 mins):Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3Health News:ECOBOND® Selected to Protect School Children in Oak Ridge Tennessee in Lead Based Paint Remediation Project. 2
... , VIRGINIA BEACH, Va., Sept. 10 ... implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( ... in Kansas City, Mo by Gary K. Lofland, ... Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri ...
... LEXINGTON, Ky., Sept. 10 VirtualHealth Technologies, Inc. (OTC Bulletin ... records and connectivity for web-based healthcare solutions, announced today an ... Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare ... will have preferred rights to market Cifra directly to end ...
... , , WASHINGTON, Sept. 10 ... and other leading medical experts today urged Americans to be vigilant ... threat to Americans, health each and every year. , , ... and Americans should begin to get vaccinated now. Seasonal vaccine supply ...
... Researchers at UC Santa Barbara have developed a new way ... to a non-harmful laser. Their results are published in a ... the American Chemical Society. "This entirely novel tool will ... with temporal and spatial control over when a gene is ...
... person,s social life could have an even greater impact than ... growing evidence that being a member of a social group ... and even the common cold. New research by ... of social groups has a positive impact on health and ...
... LOS ANGELES, Sept. 10 Award-winning actresses Edie Falco and ... public service campaign to educate cancer patients and their loved ones ... importance of learning how to manage one,s risk. , , ... http://www.prnewswire.com/mnr/amgen/39907/ , , (Photo: ...
Cached Medicine News:Health News:LifeNet Health and Children's Mercy Hospital Announce First Implant With MatrACELL(TM) Technology 2Health News:LifeNet Health and Children's Mercy Hospital Announce First Implant With MatrACELL(TM) Technology 3Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 2Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 3Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 4Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 5Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 2Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 3Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 4Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 5Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 6Health News:UCSB researchers develop drug delivery system using nanoparticles and lasers 2Health News:Groups are key to good health 2Health News:Groups are key to good health 3Health News:Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment 2Health News:Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment 3
The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....
CataRhex PRO the portable cataract extraction system with automated capsulotomy....
Phacoemulsification system is a complete anterior segment surgical instrument. Its simplified design and unique innovations provide optimal surgical performance....
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Medicine Products: